A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease
Clinical trial NCT04424056 · UNKNOWN
Trial details
- NCT number
- NCT04424056
- Sponsor
- Assistance Publique Hopitaux De Marseille
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-09-30
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.